Jump to content

Ménière's disease

From Wikipedia
Meniere's disease
head and neck disease, class of disease
Subclass ofendolymphatic hydrops, genetic otorhinolaryngologic disease, genetic disease, genetic nervous system disorder, disease Edit
Dem name afterProsper Menière Edit
Studied byaudiology Edit
Dey afflictinner ear Edit
Health specialtyotolaryngology, speech-language pathology Edit
Medical examinationaudiometry Edit
ICD-9-CM386.00, 386.0 Edit
NCI Thesaurus IDC185243 Edit

Ménière's disease (MD) be a disease of de inner ear wey be characterized by potentially severe den incapacitating episodes of vertigo, tinnitus, hearing loss, den a feeling of fullness insyd de ear.[1][2] Typically, one ear per be affected initially, buh over time, both ears cam fi be involved.[1] Episodes generally dey last from 20 minutes to a few hours,[3] plus varying time between episodes.[1] De hearing loss den ringing insyd de ears fi cam be constant over time.[2] Na dem identify Ménière's disease insyd de early 1800s by Prosper Menière.[3]

De cause of Ménière's disease be unclear, buh likely dey involve both genetic den environmental factors.[1][4] A number of theories exist for why e dey occur, wey dey include constrictions insyd blood vessels, viral infections, den autoimmune reactions.[1] About 10% of cases run insyd families.[2] Dem dey believe symptoms to occur as de result of increased fluid buildup insyd de labyrinth of de inner ear.[1] Diagnosis be based on de symptoms den a hearing test.[1] Oda conditions wey fi produce similar symptoms dey include vestibular migraine den transient ischemic attack.[4]

No cure be known.[1] Attacks often be treated plus medications to help plus de nausea den anxiety.[2] Measures to prevent attacks overall be poorly supported by de evidence.[2] A low-salt diet, diuretics, den corticosteroids fi be tried.[2] Physical therapy fi help plus balance den counselling fi help plus anxiety.[1][2] Injections into de ear anaa surgery sanso fi be tried if oda measures no be effective, buh dem be associated plus risks.[1][3] De use of tympanostomy tubes (ventilation tubes) to improve vertigo den hearing insyd people plus Ménière's disease no be supported by definitive evidence.[3]

De disease dey affect between 0.3 den 1.9 per 1,000 people.[4] De onset of Ménière's disease usually be around 40 to 60 years old.[1][5] Females be more commonly affected dan males.[4] After 5–15 years of symptoms, episodes wey dey include dizziness anaa a sensation of spinning sam times stop den de person be left plus loss of balance, poor hearing insyd de affected ear, den ringing anaa oda sounds insyd de affected ear anaa ears.[3]

References

[edit | edit source]
  1. 1 2 3 4 5 6 7 8 9 10 11 "Ménière's Disease". NIDCD. June 1, 2016. Archived from the original on 27 July 2016. Retrieved 18 July 2016.
  2. 1 2 3 4 5 6 7 Seemungal, Barry; Kaski, Diego; Lopez-Escamez, Jose Antonio (August 2015). "Early Diagnosis and Management of Acute Vertigo from Vestibular Migraine and Ménière's Disease". Neurologic Clinics. 33 (3): 619–628, ix. doi:10.1016/j.ncl.2015.04.008. ISSN 1557-9875. PMID 26231275.
  3. 1 2 3 4 5 Harcourt J, Barraclough K, Bronstein AM (2014). "Meniere's disease". BMJ (Clinical Research Ed.). 349 g6544. doi:10.1136/bmj.g6544. PMID 25391837. S2CID 5099437.
  4. 1 2 3 4 "Ménière's Disease". NIDCD. June 1, 2016. Archived from the original on 27 July 2016. Retrieved 18 July 2016.
  5. Phillips, John S.; Westerberg, Brian (2011-07-06). "Intratympanic steroids for Ménière's disease or syndrome". The Cochrane Database of Systematic Reviews (7) CD008514. doi:10.1002/14651858.CD008514.pub2. ISSN 1469-493X. PMID 21735432.
[edit | edit source]